Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 185.78

-1.4%

2:49 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Flagrante Delictu who wrote (16976)	3/9/1998 6:20:00 PM
From: Abuckatatime	Read Replies (1) of 32384

Future indication for G-CSF (and LGND's potentially new small molecule)? Clinical trial (n=40) in diabetics showing that Neupogen improved the outcome (eradication of pathogens, quicker resolution, shorter hospital stays, and shorter duration of IV antibiotics) of foot infections. In addition no G-CSF treated patients required surgery whereas four in the placebo group did, two undergoing toe amputation. In defence of the foot:(full text not available online) thelancet.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next